Markets slipped into the red in afternoon trade as the RBI's policy decision and renewed US tariff threats weighed on investor sentiment.

Pharma stocks declined over fears of U.S. tariffs, but experts remain cautiously optimistic. India’s strength in generics may shield its exporters from any sweeping changes, according to an analyst.